ResearcherHarvard UniversityActive in the last 2 years
Anne‐Laure Bulin
Matched on ORCID iD 0000-0002-2644-8626; OpenAlex author ID A5009505184. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2018: 1 paper · 2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 7
- Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020-2025). Co-author DOI 10.1039/d5cc05629b↗
- Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models. Last author DOI 10.7150/ntno.115120↗
- Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models. Last author DOI 10.1002/smsc.202400041↗
- Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2019.119421↗
- Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towar… Co-author DOI 10.1021/acs.nanolett.9b00859↗
- Tracking Photodynamic- and Chemotherapy-Induced Redox-State Perturbations in 3D Culture Models of Pancreatic Cancer: A Tool for Identifying Therapy-Induced Met… First author DOI 10.3390/jcm8091399↗
- Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids. Co-author DOI 10.18632/oncotarget.24425↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tayyaba Hasan · 4 shared papers, 2018–2019 · strength 0.40
- Paper Tracking Photodynamic- and Chemotherapy-Induced Redox-State Perturbations in 3D Culture Models of Pancreatic Cancer: A … DOI 10.3390/jcm8091399↗
- Paper Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D c… DOI 10.1016/j.biomaterials.2019.119421↗
- Paper Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Ac… DOI 10.1021/acs.nanolett.9b00859↗
- Mans Broekgaarden · 4 shared papers, 2018–2019 · strength 0.40
- Paper Tracking Photodynamic- and Chemotherapy-Induced Redox-State Perturbations in 3D Culture Models of Pancreatic Cancer: A … DOI 10.3390/jcm8091399↗
- Paper Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D c… DOI 10.1016/j.biomaterials.2019.119421↗
- Paper Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Ac… DOI 10.1021/acs.nanolett.9b00859↗
- Sarah Stelse‐Masson · 2 shared papers, 2024–2025 · strength 0.37
- Paper Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic … DOI 10.7150/ntno.115120↗
- Paper Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Effi… DOI 10.1002/smsc.202400041↗
- Souleymane Sarr · 1 shared paper, 2026 · strength 0.21
- Nadira Delhem · 1 shared paper, 2026 · strength 0.21
- Gaël S. Roth · 1 shared paper, 2026 · strength 0.21
- Hélène Burckel · 1 shared paper, 2026 · strength 0.21
- Vincent Sol · 1 shared paper, 2026 · strength 0.21
- Nicolas Jonckheere · 1 shared paper, 2026 · strength 0.21
- Girgis Obaid · 2 shared papers, 2019 · strength 0.19
- Paper Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D c… DOI 10.1016/j.biomaterials.2019.119421↗
- Paper Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Ac… DOI 10.1021/acs.nanolett.9b00859↗
- Clémentine FULBERT · 1 shared paper, 2024 · strength 0.16
- Sriram R. Anbil · 1 shared paper, 2019 · strength 0.10
- Shazia Bano · 1 shared paper, 2019 · strength 0.09
- Srivalleesha Mallidi · 1 shared paper, 2019 · strength 0.09
- Diane M. Simeone · 1 shared paper, 2019 · strength 0.09
- Jonathan P. Celli · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.